Merritt, K, McGuire, PK, Egerton, A, Aleman, A, Block, W, Bloemen, OJN
, Borgan, F, Bustillo, JR, Capizzano, AA, Coughlin, JM, De La Fuente-Sandoval, C
, Demjaha, A, Dempster, K, Do, KQ, Du, F, Falkai, P, Galinska-Skok, B, Gallinat, J, Gasparovic, C
, Ginestet, CE, Goto, N, Graff-Guerrero, A, Ho, BC
, Howes, OD, Jauhar, S, Jeon, P, Kato, T, Kaufmann, CA, Kegeles, LS, Keshavan, M, Kim, SY, Kunugi, H, Lauriello, J, Liemburg, EJ, McIlwain, ME
, Modinos, G, Mouchlianitis, ED, Nakamura, J, Nenadic, I, Öngür, D, Ota, M, Palaniyappan, L, Pantelis, C, Plitman, E, Posporelis, S, Purdon, SE, Reichenbach, JR, Renshaw, PF, Russell, BR, Sawa, A, Schaefer, M, Shungu, DC, Smesny, S, Stanley, JA, Stone, JM, Szulc, A, Taylor, R, Thakkar, K, Théberge, J, Tibbo, PG, Van Amelsvoort, T, Walecki, J, Williamson, PC, Wood, SJ, Xin, L & Yamasue, H 2021, '
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia with Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data',
JAMA Psychiatry, vol. 78, no. 6, pp. 667-681.
https://doi.org/10.1001/jamapsychiatry.2021.0380